Che-Sheng Chu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| 40Hz tACS in Treating Cognitive Function and Modulating Neurophysiology of Patients With Alzheimer's Disease (NCT05723172) | Che-Sheng Chu | 2023-09-01 |
Track Che-Sheng Chu automatically
Every clearance here is in the API, with alerts when new ones post.